GCP
NMRA icon

GSA Capital Partners’s Neumora Therapeutics NMRA Stock Holding History

GSA Capital Partners’s Portfolio NMRA Stock Details NMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$425K Sell
217,950
-316,094
-59% -$819K 0.03% 1017
2025
Q4 		$956K Buy
534,044
+425,633
+393% +$932K 0.08% 394
2025
Q3 		$197K Sell
108,411
-795,332
-88% -$1.29M 0.02% 1436
2025
Q2 		$663K Buy
903,743
+717,030
+384% +$543K 0.05% 728
2025
Q1 		$187K Buy
+186,713
New +$320K 0.02% 1407
2024
Q2 		– Sell
-29,821
Closed -$410K – 1909
2024
Q1 		$410K Sell
29,821
-17,062
-36% -$276K 0.03% 1022
2023
Q4 		$799K Buy
+46,883
New +$575K 0.07% 511

Other funds holding NMRA

SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $11.4B AUM 27.91% 1-Year Est. Return
PA
Perceptive Advisors New York $5.06B AUM 314.02% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $352M AUM 0.23% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
WT
Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
LC
Lunate Capital Al Maryah Island, Abu Dhabi, United Arab Emirates $120M AUM 72.64% 1-Year Est. Return